PuraCath Medical, Inc.
Biotechnology company · San Francisco, California, United States
PuraCath Medical, Inc. is a biotechnology company headquartered in San Francisco, California, United States. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $6.2 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $346,002 sold in a notice filed in 2020.
PuraCath Medical at a glance
What does PuraCath Medical do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $6.2 million in total (2017 to 2023). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $346,002 sold (2020).
Frequently asked questions about PuraCath Medical
Where is PuraCath Medical headquartered?
PuraCath Medical, Inc. is headquartered in San Francisco, California, United States.
What does PuraCath Medical do?
PuraCath Medical, Inc. is a biotechnology company.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences